Form 4 for MLAB MESA LABORATORIES INC /CO/
Accepted 2023-01-25 00:00:00 ET · period of report 2023-01-23 · accession 0001228924-23-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-25 | 2023-01-23 | MLAB | Sakys John | CFO | M - OptEx | $70.56 | +2,100 | 11.8K | +22% | +$148.2K |
| D | 2023-01-25 | 2023-01-23 | MLAB | Sakys John | CFO | S - Sale+OE | $210.19 | -2,100 | 9,696 | -18% | -$441.4K |
| D | 2023-01-25 | 2023-01-23 | MLAB | Sakys John | CFO | X - OptEx | $0.00 | -2,100 | 27.7K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-23 | M | A | 2,100 | $70.56 | 11,796 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-23 | S | D | 2,100 | $210.19 | 9,696 | D | — | — | (F2) Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on June 14, 2022 |
| 3 | Derivative | Non Qualified Stock Option | 2023-01-23 | X | D | 2,100 | $0.00 | 27,702 | D | $70.56 · 2016-04-01 to 2023-04-01 | 2,100 Common Stock | (F1) 1/7 exercisable on each anniversary of the 04/01/2015 grant date |